"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The distribution of 5-hydroxyindoleacetic acid (5-HIAA) concentrations in the cerebrospinal fluid of 68 depressed patients was bimodal. Twenty-nine percent of the patients were in the lower mode, with a concentration of 5-HIAA below 15 nanograms per milliliter. Although there were no differences in overall severity of depression between the two modes, there was a significant correlation between the concentration of 5-HIAA and severity of depression in the lower, but not in the upper, mode. The finding suggests the existence of a biochemical subgroup of depressive disorder, characterized by a disturbance of serotonin turnover.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The serotonin pathway is by far the best described pathway in depression and several alterations in this pathway have been associated with suicidal behaviour.”
From Suicide and suicide risk (2019) · cites this paper as [129]
Citations
Cites
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides
Shaw, D. M., Camps, F. E., & Eccleston, E. G. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.505.1407 · Cited by 431
Abnormalities of Indoleamines in Affective Disorders
Coppen, A. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750230084016 · Cited by 304
Coppen, A. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750210042009 · Cited by 245
Åsberg, M., Bertilsson, L., Tuck, D., Cronholm, B., & Sjoqvist, F. (1973) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1973142277 · Cited by 242
Self-citationvan Praag, H. M., & Korf, J. (1971) · Psychopharmacologia · doi:10.1007/bf00402638 · Cited by 225
ACID MONOAMINE METABOLITES OF CEREBROSPINAL FLUID IN MENTAL DEPRESSION AND MANIA
Dencker, S. J., Malm, U., Roos, B. ‐., & Werdinius, B. (1966) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1966.tb04320.x · Cited by 218
CRONHOLM, B., & OTTOSSON, J. (1960) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1960.tb08351.x · Cited by 193
Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients
Papeschi, R. (1971) · Archives of General Psychiatry · doi:10.1001/archpsyc.1971.01750160066012 · Cited by 179
Cerebral Monoamines and Depression: An Investigation With the Probenecid Technique
van Praag, H. M. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750360053007 · Cited by 174
Research works printed but not linked: 7
- Pare, C. M. B., Lancet 1969-II: 133 (1969).
- Lloyd, K. G., Adv. Biochem. Psychopharmacol 11: 387 (1974).
- Bourne, H. R., Lancet 1968-II: 805 (1968).
- Coppen, A., Lancet 1967-II: 1178 (1967).
- Ashcroft, G. W., Lancet 1966-II: 1049 (1966).
- Gurney, C., Proceedings of the 5th World Congress of Psychiatry: 330 (1971).
- Curzon, G., J. Psychiatr. Res. 9: 243 (1972).
Cited by
Items 301–400 of 678
Neurochemical Findings in Suicide Completers and Suicide Attempters
Stanley, M., Stanley, B., Träskman‐Bendz, L., Mann, J. J., & Meyendorff, E. (1986) · Suicide and Life-Threatening Behavior · doi:10.1111/j.1943-278x.1986.tb00356.x · Cited by 26
Dahl, L., Lundin, L. B., Honoré, P., & Dencker, S. J. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb00909.x · Cited by 26
MAO activity, csf amine metabolites, and drug-free improvement in schizophrenia
van Kammen, D. P., Marder, S. R., Murphy, D., & Bunney, W. E. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.5.567 · Cited by 26
Comings, D. E. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320600206 · Cited by 28
Bánki, C. M., Molnar, G., & Fekete, I. (1981) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf01833162 · Cited by 26
Nyström, C., & Hällström, T. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb02563.x · Cited by 27
Decoding serotonin: the molecular symphony behind depression
Shu, Y. L., Tian, L., Wang, X., Meng, T., Yu, S., & Li, Y. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1572462 · Cited by 28
“Furthermore, researchers have observed dysregulated levels of 5-HIAA, a major metabolite of 5-HT, in the cerebrospinal fluid and urine of patients with depression, which were significantly correlated with the severity of depressive symptoms (Asberg et al., 1976; Bhatia et al., 1978).”
Postmortem serotonin (5-HT) concentrations in the cerebrospinal fluid of medicolegal cases
Mußhoff, F., Menting, T. P., & Madea, B. (2004) · Forensic Science International · doi:10.1016/j.forsciint.2004.02.023 · Cited by 27
Celada, P., Sarrias, M. J., & Artigas, F. (1990) · Springer eBooks · doi:10.1007/978-3-7091-9113-2_21 · Cited by 25
Javors, M. A., Bowden, C. L., & Maas, J. W. (1984) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)85149-x · Cited by 25
Hilke, S., Theodorsson, A., Fetissov, S. O., Åman, K., Holm, L., Hökfelt, T. G. M., & Theodorsson, E. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04050.x · Cited by 25
“Serotonin is associated strongly with mood control (Åsberg et al., 1976; Lidberg et al., 2000), and galanin has been proposed to influence mood)behaviour by inhibiting 5-hydroxytryptamine release in the hippocampus (Fuxe et al., 1998; Weiss et al., 1998; Kehr et al., 2002).”
BackgroundComparison between zimelidine and desipramine in endogenous depression
Åberg‐Wistedt, A. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb00921.x · Cited by 25
Møller, S., Reisby, N., Ortmann, J., Elley, J., & Krautwald, O. (1981) · Journal of Affective Disorders · doi:10.1016/0165-0327(81)90025-2 · Cited by 25
Modulation of learned helplessness by 5-hydroxytryptamine2A receptor antisense oligodeoxynucleotides
Papolos, D. F., Yu, Y.-M., Rosenbaum, E., & Lachman, H. M. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)02935-6 · Cited by 25
Distal colon motility and clinical parameters in depression
Lechín, F., van der Dijs, B., Acosta, E., Espinosa-Gómez, F. C., Lechin, E., & Arocha, L. (1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90032-0 · Cited by 25
van der Veen, F. M., Mies, G. W., van der Molen, M. W., & Evers, E. A. T. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1176-x · Cited by 24
“A number of studies have shown that patients suffering from unipolar depression, which is often associated with a lowered 5-HT metabolism (e.g., Asberg et al. 1976; Maes and Meltzer 1995), show an altered behavioral or brain response to negative feedback stimuli (e.g., Elliott et al. 1998; Tucker…”
BackgroundSerotonin, impulsivity and suicide
Bourgeois, M.-L. (1991) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470060507 · Cited by 26
Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies
Caldecott-Hazard, S., & Schneider, L. S. S. (1992) · Synapse · doi:10.1002/syn.890100209 · Cited by 24
“For example, many studies have reported significant decreases in CSF levels of 5HIAA correlated with attempted suicide in depressed patients (Asberg et al., 1976; Banki et al., 1981; Brown et al., 1982; Traskman et al., 1981).”
Monoamine oxidase activity and serotoninergic turnover in human brain
Adolfsson, R., Gottfries, C. G., Oreland, L., Roos, B. E., Wiberg, Å., & Winblad, B. G. (1978) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(78)90069-3 · Cited by 24
Dexamethasone suppression test and mood response to methylphenidate in primary depression
Brown, P. J. B., & Brawley, P. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.8.990 · Cited by 24
Lingj�rde, O. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00558437 · Cited by 24
The clinical significance of disordered renal excretion of xanthurenic acid in depressive patients
Hoes, M. J. A. J. M., & Sijben, N. (1981) · Psychopharmacology · doi:10.1007/bf00435850 · Cited by 23
“According to other authors (Van Praag 1974; Asberg et al. 1976), a lowered activity of serotonergic neurons is a pathogenic mechanism of depression.”
Background5-HT1A Receptors in major depression
Yates, M., & Ferrier, I. N. (1990) · Journal of Psychopharmacology · doi:10.1177/026988119000400204 · Cited by 26
Onodera, T., Watanabe, R., Tha, K. K., Hayashi, Y., Murayama, T., Okuma, Y., Ono, C., Oketani, Y., Hosokawa, M., & Nomura, Y. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.83.312 · Cited by 20
Comings, D., Muhleman, D., Dietz, G., & Donlon, T. (1991) · Genomics · doi:10.1016/0888-7543(91)90257-f · Cited by 18
Noradrenergic function during stress and depression: An alternative view
Stone, E. A. (1982) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0001089x · Cited by 23
Psychotropic and Neurotropic Activity
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_6 · Cited by 24
Baseline studies on transmitter substances in cerebrospinal fluid in depression
Gjerris, A. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb10571.x · Cited by 22
Current status of the biogenic amine theory of depression
Leonard, B. E. (1982) · Neurochemistry International · doi:10.1016/0197-0186(82)90074-2 · Cited by 22
Neurochemical Aspects of Depression: The Past and the Future?
Jesberger, J. A., & Richardson, J. S. (1985) · International Journal of Neuroscience · doi:10.3109/00207458509149132 · Cited by 22
Behavioral Manifestations of Movement Disorders
Mayeux, R. P. (1984) · Neurologic Clinics · doi:10.1016/s0733-8619(18)31089-2 · Cited by 24
Nyström, C., & Hällström, T. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02805.x · Cited by 27
Liquid chromatographic assay for cerebrospinal fluid serotonin
Linnoila, M., Jacobson, K. A., Marshall, T. H., Miller, T. L., & Kirk, K. L. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90582-5 · Cited by 23
Anger, Fear, Depression, and Crime: Physiological and Psychological Studies Using the Process Method
SABELLI, H. C., Carlson‐Sabelli, L., Patel, M. K. P. M. K., Levy, A., & Diez-Martin, J. (2014) · Psychology Press eBooks · doi:10.4324/9781315806280-8 · Cited by 22
Revisiting the role of raphe and serotonin in neuropsychiatric disorders
Adell, A. (2015) · The Journal of General Physiology · doi:10.1085/jgp.201511389 · Cited by 23
Postmortem and Regional Changes of Serotonin, 5‐Hydroxyindoleacetic Acid, and Tryptophan in Brain
McIntyre, I. M., & Stanley, M. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb12746.x · Cited by 21
“However, the majority of evidence supporting this hypothesis has been obtained by indirect measures such as serotonin (5-HT) uptake (Tuomisto and Tukianinen, 1976), cerebrospinal fluid levels of 5-hydroxyindoleacetic acid (5-HIAA) (Asberg et al., 1976), or imipramine binding to platelets (Briley et al.”
BackgroundAlgeri, S., Catto, E., Curcio, M., Ponzio, F., & Stramentinoli, G. (1979) · Elsevier eBooks · doi:10.1016/b978-0-08-024929-2.50013-1 · Cited by 21
Faull, C., Rooke, P., & Baylis, P. H. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03560.x · Cited by 21
EVOLUTION OF THE MONOAMINE HYPOTHESES OF DEPRESSION
Pryor, J. C., & Sulser, F. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-356510-5.50009-1 · Cited by 27
Neurochemical correlates of stress and depression: Depletion or disorganization?
Kraemer, G. W. (1982) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00010761 · Cited by 22
Neuroticism and anxious attachment as potential vulnerability factors of repeat suicide attempts
Pennel, L., Quésada, J.-L., & Demattéis, M. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.03.064 · Cited by 22
Nevado, J. J. B., Contento, A. M., & Villaseñor, M. J. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(01)00638-9 · Cited by 20
Rifai, A. H., Reynolds, C. F., & Mann, J. J. (1992) · Suicide and Life-Threatening Behavior · doi:10.1111/j.1943-278x.1992.tb00475.x · Cited by 23
Leonard, B. E. (1986) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470010103 · Cited by 20
Bharucha, A. J., & Satlin, A. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709034728 · Cited by 21
Thyroid Hormone, Brain, and Behavior
Bauer, M., & Whybrow, P. C. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50023-8 · Cited by 29
Curzon, G., Knott, P. J., & Golberg, L. (1977) · Critical Reviews in Toxicology · doi:10.3109/10408447709003378 · Cited by 20
Åberg‐Wistedt, A., Ross, S. B., Jostell, K. ‐., & Sjöquist, B. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb00915.x · Cited by 23
Van Assche, E., Moons, T., Cinar, O., Viechtbauer, W., Oldehinkel, A. J., Van Leeuwen, K., Verschueren, K., Colpin, H., Lambrechts, D., Van den Noortgate, W., et al. (2017) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12766 · Cited by 19
“Unlike most existing theories for depression and depressive symptoms that focus on serotonin and its transporter (Asberg, Thoren, Traskman, Bertilsson, & Ringberger, 1976; Owens & Nemeroff, 1994; Uher & McGuffin, 2010; Whittington et al., 2004), these results seem to support recent findings showing…”
Amino acid challenge and depletion techniques in human functional neuroimaging studies: an overview
Biskup, C. S., Gaber, T. J., Helmbold, K., Bubenzer‐Busch, S., & Zepf, F. D. (2015) · Amino Acids · doi:10.1007/s00726-015-1919-z · Cited by 19
“Memory Serotonin is suggested to be essential for memory function (Asberg et al. 1976).”
BackgroundElectroconvulsive therapy regulates emotional memory bias of depressed patients
Bai, T., Xie, W., Wei, Q., Chen, Y., Mu, J., Tian, Y., & Wang, K. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.07.069 · Cited by 21
Analytical methods for determination of selective serotonin reuptake inhibitor antidepressants
Şentürk, Z., Saka, C., & Teğin, İ. (2011) · Reviews in Analytical Chemistry · doi:10.1515/revac.2011.018 · Cited by 19
Biochemical aspects of suicidal behavior
Träskman‐Bendz, L., Åsberg, M., Nordström, P., & Stanley, M. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90108-5 · Cited by 20
Self-citationCSF biochemical correlates of mixed affective states
Tandon, R., Channabasavanna, S. M., & Greden, J. F. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06339.x · Cited by 19
Indoleamines in Depression and Suicide
van Praag, H. M. (1986) · Progress in brain research · doi:10.1016/s0079-6123(08)60642-1 · Cited by 19
Serotonin 1A receptor genetic variations, suicide, and life events in the Iranian population
Samadirad, B., Ghasemi, A., Seifi, M., Samadikuchaksaraei, A., Baybordi, F., & Danaei, N. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02333.x · Cited by 18
5HTTLPR predicts left fusiform gyrus activation to positive emotional stimuli
Demaree, H. A., Pu, J., Jesberger, J. A., Feeny, N. C., Jeng, L. B., Everhart, D. E., Duerk, J. L., & Tkach, J. A. (2008) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2008.08.006 · Cited by 19
High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains
Rosel, P., Arranz, B., Vallejo, J., Oros, M., Menchón, J. M., Álvarez, P., & Navarro, M. A. (1997) · Journal of Neural Transmission · doi:10.1007/bf01285560 · Cited by 20
“This alteration may be of presynaptic and/ or postsynaptic nature, or in other words, may be related to synthesis, metabolism, release, reuptake, postsynaptic binding sites and second messenger modification both in platelet and neural membranes ( Asberg et al., 1976; Murphy et al., 1978; Montgomery, 1982; Mann et al.,…”
5-HT and Depression: the Present Position
Coppen, A., & Swade, C. (1988) · doi:10.1007/978-1-349-09506-3_9 · Cited by 20
Pathological lying associated with thalamic dysfunction demonstrated by [99mTc]HMPAO SPECT
Modell, J. G., Mountz, J. M., & Ford, C. V. (1992) · Journal of Neuropsychiatry · doi:10.1176/jnp.4.4.442 · Cited by 18
Åsberg, M., & Wägner, A. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513361.ch5 · Cited by 18
Self-citationRelationship between alpha2-adrenergic function and suicidal behavior in depressed patients
Pitchot, W., Ansseau, M., Moreno, A. G., Wauthy, J., Hansenne, M., & von Frenckell, R. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90081-7 · Cited by 18
Wang, X., Su, Y., Liu, Q., Li, M., Zeighami, Y., Fan, J., Adams, G. C., Tan, C., Zhu, X., & Meng, X. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105756 · Cited by 20
Psychopharmacology and the Etiology of Psychopathologic States: Are We Looking in the Right Way?
Katz, M. M., & Maas, J. W. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.16 · Cited by 21
Monoamines in the brain cerebrospinal fluid of facial pain patients.
Bouckoms, A. J., Sweet, W. H., Poletti, C., Lavori, P. W., Carr, D. B., Matson, W. R., Gamache, P. H., & D, N. A. M. (1992) · PubMed Central · Cited by 17
Low, B. P., & Andrews, S. F. (1990) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30514-4 · Cited by 17
Leckman, J. F., Charney, D. S., Nelson, C., Heninger, G. R., & Bowers, M. B. (1981) · Elsevier eBooks · doi:10.1016/b978-0-08-026382-3.50042-6 · Cited by 17
Serial DST, TRH test, and TRH-like immunoreactivity measurements in major affective disorders
Itoh, N., Matsui, N., Fuwano, S., Yaginuma, H., Miyashita, O., & Sakai, M. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90184-3 · Cited by 17
Waselus, M., & Bockstaele, E. J. V. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.014 · Cited by 21
Balldin, J., Cg, G., Karlsson, I., Lindstedt, G., Lérngström, G., & Svennerholm, L. T. (1988) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930030104 · Cited by 17
(2000) · The Canadian Journal of Psychiatry · doi:10.1177/070674370004500115 · Cited by 17
Sung, H. G., Li, J., Nam, J. H., Won, D. Y., Choi, B., & Shin, J. (2019) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-019-01713-x · Cited by 17
Zhi, M., Hou, Z., We, Q., Zhang, Y., Li, L., & Yuan, Y. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.020 · Cited by 17
Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.
Pd, H. (1991) · PubMed Central · Cited by 16
Rimón, R., Fujita, M., & Takahata, N. (1986) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1986.tb03137.x · Cited by 16
Enhanced serum cortisol response to 5-hydroxytryptophan in depression and mania
Meltzer, H. Y., Uberkoman-Witta, B., Robertson, A., Tricou, B. J., & Lowy, M. T. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90164-9 · Cited by 16
Møller, S. E. (1980) · Psychiatry Research · doi:10.1016/0165-1781(80)90031-1 · Cited by 16
Systematic Treatment Approach to Depression and Treatment Resistant Depression
Gerner, R. H. (1983) · Psychiatric Annals · doi:10.3928/0048-5713-19830101-07 · Cited by 16
Neuroendocrine Secretion and Biological Rhythms in Man
Wagner, D. R., & Weitzman, E. D. (1980) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30964-x · Cited by 16
Biological aspects of suicidal behaviour
Mann, J. J., & Currier, D. (2020) · doi:10.1093/med/9780198713005.003.0127 · Cited by 15
Recoverable Hearing Loss with Amphetamines and Other Drugs
Iqbal, N. (2004) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2004.10399740 · Cited by 15
Nordin, C. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06411.x · Cited by 16
New antidepressants and 5‐HT uptake inhibitors
Montgomery, S. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07187.x · Cited by 19
Zimelidine vs maprotiline in depressed outpatients A preliminary report
d'Elia, G., Hällström, T., Nyström, C., & Ottosson, J. (1981) · Acta Psychiatrica Scandinavica Supplementum · doi:10.1111/j.1600-0447.1981.tb00724.x · Cited by 21
Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex
Hatanaka, K.-I., Yatsugi, S., & Yamaguchi, T. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00174-6 · Cited by 15
Risk of Suicidality in Depression with Serotonergic Antidepressants
Matthews, J., & Fava, M. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009027010991 · Cited by 15
The dexamethasone suppression test: Clinical applications
Brown, W. A. (1981) · Psychosomatics · doi:10.1016/s0033-3182(81)73456-x · Cited by 15
The Biology of Affective Illness: Amine Neurotransmitters and Drug Response
Goodwin, F. K., & Potter, W. Z. (1978) · Springer eBooks · doi:10.1007/978-1-4684-2397-6_3 · Cited by 15
Soda, E., Miura, I., Hoshino, H., Kanno‐Nozaki, K., Ota, T., Oguchi, H., Watanabe, K., Yang, Q., Mashiko, H., & Niwa, S. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.08.031 · Cited by 14
“Concentrations of monoamine metabolites have been studied (Beckmann and Goodwin, 1975; Asberg et al., 1976; Carlsson et al., 1985; Nagaoka et al., 1997; Kelly et al., 1999; Luykx et al., 2012) with relation to psychiatric disorders, such as schizophrenia or depression.”
BackgroundPsychotropic and neurotropic activity1
Vogel, H. G., Vogel, W. H., Schölkens, B. A., Sandow, J., Müller, G. A., & Vogel, W. F. (2002) · Springer eBooks · doi:10.1007/3-540-29837-1_6 · Cited by 14
Serotonin function is associated with behavioral response to a novel conspecific in marmosets
Kinnally, E. L., Jensen, H. A., Ewing, J. H., & French, J. A. (2006) · American Journal of Primatology · doi:10.1002/ajp.20281 · Cited by 14
“, 2002], as well as levels of CSF 5-hydroxy-3-indoleacetic acid (5-HIAA), a 5-HT metabolite, are stable within individuals over time (humans [Asberg et al., 1976] and macaques [Higley & Linnoila, 1997; Anderson et al.”
BackgroundAbout the course of schizoaffective psychoses
van Praag, H. M., & Nijo, L. (1984) · Comprehensive Psychiatry · doi:10.1016/0010-440x(84)90017-8 · Cited by 14
The clinical pharmacology of appetite – its relevance to psychiatry
Silverstone, T. (1983) · Psychological Medicine · doi:10.1017/s0033291700050856 · Cited by 14
“A good case has also been made out for an involvement of serotonergic (5HT) pathways in the pathogenesis of depression, particularly in patients who manifest suicidal behaviour (Asberg et al. 1976).”
BackgroundIdentifying Alcoholism Vulnerability Alleles
Goldman, D. A. (1995) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb00953.x · Cited by 14
Takahashi, T. (2011) · arXiv · doi:10.48550/arxiv.1111.6488
“In order to describe impulsivity and irrationality in temporal discounting, the q-exponential time-discount model for delayed rewards has been introduced and experimentally examined (Cajueiro, 2006; Takahashi, 2007; Takahashi et al., 2007a; Takahashi et al., 2008ab; Takahashi, 2009): Vq+(D)= Vq+ (0)/ expq+(kq+D)= Vq+…”
BackgroundInfluentialFraction I Endorphin in Cerebrospinal Fluid Clinical Studies
von Knorring, L., Terenius, L. Y., & Wahlström, A. (1983) · Springer eBooks · doi:10.1007/978-1-4615-9269-3_6 · Cited by 14
Pathophysiology and Medical Management of Hypoactive Sexual Desire Disorder
Clayton, A. H., & Vignozzi, L. (2018) · Wiley eBooks · doi:10.1002/9781119266136.ch6 · Cited by 15
Mecanismos de ocorrência de dor
Teixeira, M. J. (2001) · Revista de Medicina · doi:10.11606/issn.1679-9836.v80ispe1p22-62 · Cited by 13
The serotonin transporter knock-out rat: a review
Olivier, J., Cools, A. R., Ellenbroek, B. A., Cuppen, E. P. J. G., & Homberg, J. R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511729935.007 · Cited by 15
Opioid Peptides in the Cerebrospinal Fluid of Psychiatric Patients
Terenius, L. Y., & Nyberg, F. (1986) · Progress in brain research · doi:10.1016/s0079-6123(08)60652-4 · Cited by 13
Metadata
- Authors
- Åsberg, M., Thorén, P., Traskman, L., Bertilsson, L., & Ringberger, V.
- Affiliations
- Karolinska Institutet (SE)
- Karolinska Institute, Department of Psychiatry, Karolinska Hospital, S-J04 OJ Stockholm 60, Sweden
- Karolinska Institute, Department of Clinical Pharmacology, Huddinge Hospital, S-J41 86 Huddinge, Sweden
- Venue
- Science
- Published
- 1976-02-06
- Volume
- 191
- Issue
- 4226
- Pages
- 478-480
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2030998472
- Cited by
- 682
- References
- 20
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 6 · 2023: 3 · 2022: 2 · 2021: 8 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 6 · 2016: 5 · 2015: 10 · 2014: 9 · 2013: 5 · 2012: 6
- FWCI
- 25.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- 5-hydroxyindoleacetic acid, cerebrospinal fluid, depression, serotonin turnover, depression severity, mood disorders
- MeSH terms
- Antidepressive Agents, Depression, Female, Humans, Hydroxyindoleacetic Acid, Male, Serotonin, Sex Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.